the niche thionamide
A second-line antithyroid drug reserved for specific high-stakes situations due to its risk of severe hepatotoxicity. Preferred only in 1st Trimester Pregnancy, Thyroid Storm, and minor reactions to Methimazole.
- Mechanism:
- Inhibits Thyroid Peroxidase (TPO) (blocks synthesis).
- Inhibits Type 1 Deiodinase: Blocks peripheral conversion of T4 T3 (rapidly lowers active hormone).
- Dosing:
- Hyperthyroidism: 100–300 mg PO divided TID (short half-life).
- Thyroid Storm: Loading dose 500–1000 mg, then 250 mg q4h.
- PK: Half-life: 1–2 hours (requires TID dosing). High protein binding (less placental transfer than MMI, though clinical relevance debated).
indications
- Hyperthyroidism in Pregnancy (Trimester 1): Reduced teratogenicity compared to Methimazole.
- Thyroid Storm: Benefit of blocking T4 T3 conversion.
- Methimazole Intolerance: Minor reactions (rash) only. Do not switch if agranulocytosis occurred.
adverse effects
- Black Box Warning: Severe Liver Injury/Acute Liver Failure. Can be fatal. Monitor LFTs (though sudden onset makes monitoring imperfect).
- Agranulocytosis: Similar risk to Methimazole.
- ANCA Vasculitis: Associated with long-term use.
related pages: Methimazole, Thyroid Storm, Hyperthyroidism in Pregnancy